Register
Login:
Share:
Email Facebook Twitter




AVCT Share Chat - RSS Feed

Avacta Share Chat (AVCT)



Share Price: 0.845Bid: 0.83Ask: 0.86Change: 0.00 (0.00%)No Movement on Avacta
Spread: 0.03Spread as %: 3.61%Open: 0.845High: 0.845Low: 0.845Yesterday’s Close: 0.845


Share Discussion for Avacta (AVCT)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Premium Membership
byebyebye
Posts: 66
Off Topic
Opinion:Strong Buy
Price:1.21
Int results
23 Apr '14
Onwards and upwards,
sp will rise as the year goes on I'm sure,
 
wintzy
Posts: 292
Off Topic
Opinion:No Opinion
Price:1.17
Int Results
23 Apr '14
GedW
Posts: 10,798
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:1.16
Pancreatitis launch
14 Apr '14
has completed development and validation of a new test for pancreatitis in dogs.

Pancreatitis is a very common inflammatory disorder of the pancreas in dogs of which there are 83 million in the US and 8.5 million in the UK. The acute form of the disease occurs in around 1.5% of dogs whilst the prevalence of the chronic form is reported to be as high as 30% suggesting a large market for a pancreatitis diagnostic test. However, the market is even larger than the prevalence of the disease alone would suggest because most dogs with pancreatitis present with common gastrointestinal signs of upset, such as vomiting, anorexia, painful abdomen, hunched posture, diarrhoea, fever, dehydration and lack of energy; with vomiting being the most common symptom. Consequently, a much larger number of animals would be screened for pancreatitis than may eventually be diagnosed with the disorder.

Avacta's new pancreatitis test utilises the same approach as its unique canine lymphoma blood test in which an algorithm is used to combine the results of two common blood tests with other symptoms and other information about the dog such as age and breed. Currently there is only one other proprietary test for pancreatitis in the market. Avacta's internal validation of its new pancreatitis test performance shows that is has better sensitivity, specificity and predictive capability than the established test when tested on confirmed pancreatitis cases clinically diagnosed by vets at a large referral centre in the UK using other techniques such as ultrasound.

Avacta will commercialise the test by providing "pay per click" access to the diagnostic algorithm which will allow veterinary laboratories world wide to get an accurate and immediate diagnosis for pancreatitis by submitting the results of two blood tests commonly run in house along with other patient information on-line. In due course the blood tests themselves will also be offered on the Sensipod in-clinic analyser allowing vets to access the same on-line pancreatitis diagnostic.
WALBROOKPRIR
Posts: 8
Off Topic
Opinion:No Opinion
Price:1.16
Post from Walbrook PR
8 Apr '14
We are Walbrook PR who handle the financial PR for Avacta Group PLC. If you are interested in taking a virtual tour of the premises, please see the link attached. If you would like to tour the facility, we will be able to organise this so please contact us at avacta@walbrookpr.com

http://www.avacta.com/investor-relations/virtual-tour
Poacher886
Posts: 1,377
Off Topic
Opinion:No Opinion
Price:1.16
RNS
20 Mar '14
Nothing new to what was said in the presentation though is it?, just a re-hash of what we already know.
wintzy
Posts: 292
Off Topic
Opinion:No Opinion
Price:1.13
RNS
20 Mar '14
A very positive RNS, indeed it is written in an understated way. Things should move quickly now.
cipro
Posts: 903
Off Topic
Opinion:No Opinion
Price:1.23
Slow
13 Feb '14
Back up slightly this must do better soon they seem tobe doing the right thing although they are short of cash
Suzz
Posts: 5,160
Off Topic
Opinion:No Opinion
Price:1.22
.25
7 Feb '14
Nice tick up at the end of the day :)
Suzz
Posts: 5,160
Off Topic
Opinion:No Opinion
Price:1.20
clogheen
7 Feb '14
Looking interesting chartwise......
clogheen
Posts: 1,397
Observation
Opinion:No Opinion
Price:1.20
On the website
7 Feb '14
http://www.avacta.com/news/recentupdates/investor-teach-in-webcast

Feeling very positive on AVCT,,,,,,,,,,,let's see where this year takes us :-)





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.